Gadolinium-based contrast agents (GBCAs) can often bring out the best in MRI, but they’re controversial and thus increasingly avoided. A pilot study in Germany shows how an algorithm might substitute for an injection to track tumors of the brain and spinal cord (aka gliomas).
While Google has ventured into the healthcare field with various technologies and tools, it is also collecting vast amounts of healthcare data through these tools and through deals with healthcare stakeholders.
Aided by augmented reality, AI and portable neuroimaging technology, physicians may soon be able to tease out images of patients’ brains—right there in the doctor’s office—to see how much pain each patient is suffering.
Hospital operating rooms hoping to keep up with their competition during a forecasted $2.5 billion spending spree need to invest in integrating robotics to improve precision, virtual reality to inform pre-surgery planning and AI to analyze risks.
Mount Sinai Health System, a New York-based hospital network, is working on a series of digital news segments with Discovery’s Science Channel to reveal innovations in science and medicine, including AI.
An initial set of studies went up this week at medRxiv, a new and somewhat controversial online outlet hosting preprinted clinical research reports—they haven’t yet been subject to peer review, much less journal editing—and the batch includes one dealing with AI.
Paralleling its drive for greater transparency in hospital and insurer pricing, the Trump Administration is calling for AI to be made more readily understandable in all industries using it, including healthcare.